eGFR: When to Order This Kidney Function Test

What eGFR Actually Measures

The estimated glomerular filtration rate quantifies how many milliliters of blood your kidneys filter per minute, normalized to a standard body surface area of 1.73 m². It is not measured directly. Instead, labs calculate it from your serum creatinine concentration using the CKD-EPI 2021 equation, which also factors in age and sex [1]. The National Kidney Foundation and KDIGO jointly recommended this race-free equation in 2021, replacing older formulas that included a race coefficient [2].

Creatinine is a waste product generated by normal muscle metabolism. Healthy kidneys clear it efficiently. When kidney filtration declines, creatinine accumulates in the blood, and the calculated eGFR drops. A single eGFR value is a snapshot. Two or more values separated by at least 90 days establish a trend, which is what clinicians need to diagnose chronic kidney disease (CKD) or confirm stable function before prescribing certain drugs.

Some labs now also report cystatin C-based eGFR, which can be more accurate in patients with unusually high or low muscle mass. The 2024 KDIGO guidelines recommend confirming borderline creatinine-based eGFR results with a cystatin C measurement, particularly when eGFR falls between 45 and 59 mL/min/1.73 m² [3].

Normal eGFR Ranges and CKD Staging

A normal eGFR in a healthy young adult typically falls between 90 and 120 mL/min/1.73 m². Values above 90 without proteinuria or structural kidney damage are classified as normal. eGFR naturally declines with age, roughly 1 mL/min/1.73 m² per year after age 40 according to longitudinal data published in the Journal of the American Society of Nephrology [4].

The KDIGO staging system classifies CKD by eGFR and albuminuria:

• G1: eGFR ≥ 90 (normal or high, but kidney damage present based on albuminuria or imaging)
• G2: eGFR 60 to 89 (mildly decreased)
• G3a: eGFR 45 to 59 (mild to moderate decrease)
• G3b: eGFR 30 to 44 (moderate to severe decrease)
• G4: eGFR 15 to 29 (severely decreased)
• G5: eGFR <15 (kidney failure)

A single low reading does not equal CKD. Dehydration, recent intense exercise, high protein intake, or certain medications (trimethoprim, cimetidine) can temporarily raise creatinine and suppress eGFR. The diagnosis requires two abnormal values at least 90 days apart, combined with evidence of kidney damage such as albuminuria above 30 mg/g [5].

When Your Clinician Should Order eGFR

The ADA Standards of Care 2024 recommend annual eGFR and urine albumin-to-creatinine ratio (UACR) screening for all patients with type 2 diabetes, starting at diagnosis [6]. For type 1 diabetes, screening begins 5 years after diagnosis. The USPSTF currently finds insufficient evidence for screening in asymptomatic adults without risk factors but acknowledges the value of targeted screening in high-risk groups [7].

Order eGFR testing in these clinical situations:

Baseline screening for patients with diabetes (type 1 or type 2), hypertension, cardiovascular disease, obesity (BMI ≥ 30), a family history of kidney disease, or age over 60 with any cardiometabolic risk factor.

Before starting or adjusting renally cleared medications. This is the scenario most relevant to HealthRX patients. Metformin requires eGFR verification: the FDA label permits initiation at eGFR ≥ 45, recommends dose reduction at eGFR 30 to 45, and contraindicates use below 30 [8]. GLP-1 receptor agonists (semaglutide, tirzepatide, liraglutide) do not require renal dose adjustments, but the FLOW trial (N=3,533) demonstrated that semaglutide 1.0 mg slowed eGFR decline by 1.16 mL/min/1.73 m² per year compared to placebo in patients with type 2 diabetes and CKD [9]. Monitoring eGFR in these patients tracks both disease progression and treatment response.

During testosterone replacement therapy (TRT). Testosterone can increase creatinine production by raising muscle mass, which may artificially lower calculated eGFR without actual renal impairment. The Endocrine Society 2018 guidelines recommend baseline metabolic panels, including creatinine, before initiating TRT [10].

After acute illness, hospitalization, or surgery. Acute kidney injury (AKI) is common in hospitalized patients, and a post-discharge eGFR confirms recovery or flags the need for ongoing nephrology monitoring.

How eGFR Guides Medication Dosing in Telehealth

Renal dosing decisions affect a large share of prescriptions written through telehealth hormone and metabolic health platforms. The practical cutoffs clinicians use daily are straightforward.

For metformin: the maximum daily dose (2,000 to 2 to 550 mg) is appropriate at eGFR ≥ 45. Between eGFR 30 and 45, the ADA recommends reducing the dose to 1 to 000 mg/day and rechecking eGFR every 3 months [6]. Below 30, metformin should be stopped due to lactic acidosis risk.

For SGLT2 inhibitors (empagliflozin, dapagliflozin): these drugs retain cardiorenal protective effects at lower eGFR values. The DAPA-CKD trial (N=4,304) showed that dapagliflozin reduced the composite of sustained eGFR decline ≥ 50%, end-stage kidney disease, or renal death by 39% (HR 0.61 to 95% CI 0.51 to 0.72) in patients with eGFR 25 to 75 [11]. Current FDA labeling allows initiation of dapagliflozin down to eGFR 25 for CKD indications.

For GLP-1 receptor agonists: no renal dose adjustment is required for semaglutide or tirzepatide across all eGFR ranges. Liraglutide (Saxenda/Victoza) also requires no adjustment, though GI side effects may worsen dehydration risk at lower eGFR values.

For testosterone cypionate: no formal eGFR-based dose adjustment exists, but creatinine-based eGFR may underestimate true kidney function in men gaining muscle mass on TRT. If eGFR appears to drop after TRT initiation, a cystatin C-based eGFR confirmation can prevent unnecessary dose reductions or referrals.

How Often to Retest eGFR

Testing frequency depends on CKD stage and rate of decline. KDIGO 2024 provides a heat map combining eGFR stage and albuminuria category to set monitoring intervals [3]:

• eGFR ≥ 60 with no albuminuria: retest annually
• eGFR 45 to 59 (G3a) or albuminuria 30 to 300 mg/g (A2): retest every 6 months
• eGFR 30 to 44 (G3b) or albuminuria above 300 mg/g (A3): retest every 3 months
• eGFR <30 (G4/G5): retest every 1 to 3 months and involve nephrology

A rapid decline, defined as an eGFR drop exceeding 5 mL/min/1.73 m² per year, warrants investigation regardless of the absolute value. Causes include uncontrolled hypertension, NSAID overuse, recurrent urinary obstruction, or progression of diabetic kidney disease. The AACE 2023 consensus statement on obesity also recommends eGFR monitoring at 3- and 6-month intervals after bariatric surgery, since rapid weight loss can transiently alter creatinine kinetics [12].

For patients on stable GLP-1 therapy with eGFR above 60 and no albuminuria, annual retesting is sufficient. If eGFR sits between 45 and 60, the clinician should pair each retest with a UACR to capture early albuminuria, which often precedes further eGFR decline.

What a High eGFR Means

An eGFR above 120 mL/min/1.73 m² is called glomerular hyperfiltration. This is not a sign of superior kidney health. In early type 2 diabetes, the kidneys compensate for metabolic stress by filtering at abnormally high rates, a process that damages the glomerular capillaries over time. A 2019 meta-analysis (20 studies, N=11,515) found that hyperfiltration in diabetic patients was associated with a 2.7-fold higher risk of subsequent eGFR decline and albuminuria [13].

Hyperfiltration also occurs in obesity independent of diabetes. One mechanism involves increased intra-abdominal pressure and elevated renal plasma flow. Losing 10% or more of body weight, whether through GLP-1 therapy, tirzepatide, or metabolic surgery, can normalize hyperfiltration. In the STEP-1 trial (N=1,961), semaglutide 2.4 mg produced 14.9% mean weight loss at 68 weeks vs. 2.4% with placebo [14]. Post-hoc renal analyses from the STEP program showed improvements in UACR, though eGFR shifts were modest in participants with normal baseline function.

If your eGFR comes back above 120 and you have diabetes, prediabetes, or a BMI over 30, that number deserves attention, not reassurance.

What a Low eGFR Means and How to Respond

An eGFR below 60 that persists on repeat testing means your kidneys are filtering at reduced capacity. The clinical response depends on the cause and trajectory.

Confirm the result. Recheck in 2 to 4 weeks if the low reading is new. Rule out reversible causes: dehydration, recent creatine supplementation, NSAID or PPI use, urinary tract obstruction, and acute illness.

Add cystatin C. If the creatinine-based eGFR is borderline (45 to 59), a cystatin C-based calculation provides a second estimate that is less affected by muscle mass, diet, or supplements. Dr. Andrew Levey, a principal architect of the CKD-EPI equations, has stated: "Cystatin C confirms or reclassifies about 1 in 3 patients initially staged by creatinine alone" [15].

Start renoprotective therapy. The 2024 ADA Standards of Care recommend an ACE inhibitor or ARB for all patients with diabetes and albuminuria above 30 mg/g, regardless of blood pressure [6]. Adding an SGLT2 inhibitor provides additional nephroprotection independent of glycemic control. As stated in the 2024 KDIGO CKD guideline: "SGLT2 inhibitors are recommended for patients with CKD and eGFR ≥ 20 mL/min/1.73 m² with or without type 2 diabetes" [3].

Adjust medications. Review all prescriptions for renal dosing requirements. Common telehealth medications needing adjustment: metformin (reduce or stop below eGFR 45/30), spironolactone (increased hyperkalemia risk below eGFR 30), and certain antibiotics.

Lifestyle Factors That Affect eGFR

Blood pressure is the single most modifiable factor influencing long-term eGFR trajectory. The SPRINT trial (N=9,361) demonstrated that targeting systolic BP <120 mmHg reduced the composite renal outcome by 15% compared to standard control (<140 mmHg), though the benefit was driven primarily by albuminuria reduction rather than eGFR preservation [16].

Dietary protein intake affects creatinine generation and, to a modest degree, actual filtration. Chronic high-protein diets (above 2 g/kg/day) may accelerate eGFR decline in patients who already have CKD stage 3 or higher. In patients with normal kidney function, high protein intake raises creatinine production and can make eGFR appear lower than true GFR without causing real damage. The 2020 KDOQI nutrition guidelines recommend 0.55 to 0.60 g/kg/day of protein for CKD G3 to G5 patients not on dialysis [17].

Hydration matters acutely. Dehydration concentrates creatinine and can drop eGFR by 5 to 15 points on a single draw. Patients using GLP-1 agonists should be especially attentive to fluid intake, since nausea and reduced appetite may decrease water consumption. Before attributing a low eGFR to kidney disease, confirm the patient was adequately hydrated at the time of the draw.

NSAID avoidance is non-negotiable for anyone with eGFR below 60. Ibuprofen, naproxen, and other NSAIDs constrict the afferent arteriole and can trigger acute kidney injury, particularly when combined with an ACE inhibitor or ARB and a diuretic (the so-called "triple whammy" combination) [18].

Regular aerobic exercise (150 minutes per week of moderate intensity) has been associated with slower eGFR decline in observational studies. A 2021 meta-analysis of 12 RCTs (N=1,067) found that structured exercise improved eGFR by a mean of 2.16 mL/min/1.73 m² compared to usual care in CKD patients [19].

Preparing for an eGFR Blood Test

No special preparation is required. Unlike fasting glucose or lipid panels, eGFR can be drawn at any time of day without fasting. Drink normal amounts of water beforehand to avoid dehydration-related creatinine spikes.

Avoid intense exercise for 24 to 48 hours before the test. Heavy resistance training or endurance events transiently raise serum creatinine by 10 to 20%, which would artificially lower the calculated eGFR. Stop creatine monohydrate supplements at least 3 days before the draw if possible, since exogenous creatine is converted to creatinine and can depress the result by up to 10 to 15 points.

Tell your prescriber about all medications you take. Trimethoprim (Bactrim) and cobicistat (in some HIV regimens) inhibit tubular secretion of creatinine, raising serum levels without true filtration decline. A prescriber unaware of this interaction may misinterpret the eGFR as worse than reality.

Results arrive within 24 hours from most commercial labs. Your eGFR number will appear on the metabolic panel automatically. No additional test code is needed since labs calculate it from the creatinine value using the CKD-EPI 2021 equation.